International Scholarly Research Notices / 2013 / Article / Tab 13 / Review Article
Sexually Transmitted Infections and Male Circumcision: A Systematic Review and Meta-Analysis Table 13 Studies of the association between circumcision status and the prevalence of genital human papillomavirus infection.
Study Intact +ve/−ve Circumcised +ve/−ve Odds ratio 95% confidence interval Exact odds ratio Exact confidence interval
Aynaud et al. [33 ] 383/354 119/144 1.31 0.99–1.74 1.3089 0.9773–1.7551
Aynaud et al. [34 ] 93/69 20/28 1.89 0.98–3.62 1.8812 0.9354–3.8412 Baldwin 46/112 46/186 1.66 1.04–2.66 1.6585 1.0074–2.7333 Bleeker; group A A: 18/52 3/10 1.15 0.29–4.67 1.1519 0.2562–7.2315 Bleeker; group B 93/67 8/2 0.35 0.07–1.69 0.3489 0.0350–1.8257 Castellsagué; Brazil 40/63 1/5 3.17 0.36–28.18 3.1470 0.3344–153.8345 Castellsagué; Columbia 52/183 0/4 2.57 0.14–48.60 1.4849 0.1824–[12.0884]* Castellsagué; Philippines 2/20 12/221 1.84 0.38–8.81 1.8362 0.1870–9.1816 Castellsagué; Spain 37/278 1/36 4.79 0.64–35.99 4.7785 0.7551–199.6211 Castellsagué; Thailand 35/ 136 2/35 4.50 1.03–19.64 4.4810 1.0600–40.2844
Giuliano et al. [102 ]; any HPV† NA NA 0.97 0.68–1.39 0.97 0.68–1.39
Giuliano et al. [102 ]; high risk
NA NA 0.93 0.63–1.33 0.93 0.63–1.33 Hernandez 14/44 52/144 0.88 0.44–1.74 0.8816 0.4113–1.8042 Lajous 365/465 28/67 1.88
1.18–2.98 1.8770 1.1631–3.0978 Mandal 22/66 6/11 0.61 0.20–1.85 0.6142 0.1815–2.2693 Müller; any HPV† 125/29 35/19 2.34 1.17–4.66 2.3092 1.0971–4.8997 Müller; high risk# 80/74 23/31 1.46 0.78–2.72 1.4545 0.7454–2.8691 Müller; low risk 124/30 34/20 2.43 1.23–4.81 2.4198 1.1521–5.0476 Ng’ayo 136/96 8/10 1.77 0.67–4.65 1.7667 0.6028–5.3567 Nielson; any HPV† 38/36 199/190 1.01 0.61–1.66 1.0078 0.5942–1.7117 Nielson; high risk# 23/51 112/227 0.91
0.53–1.57 0.9142 0.5062–1.6133 Oglivie; any HPV† 89/41 94/38 0.88 0.52–1.49 0.8780 0.4997–1.5397 Oglivie; high risk# 25/105 38/94 0.59 0.33–1.05 0.5902 0.3160–1.0877 Oriel 151/69 40/28 1.53 0.87–2.68 1.5295 0.8362–2.7769 Rombaldi 47/42 7/3 0.48 0.12–1.97 0.4830 0.0758–2.2850 Shin 3/40 29/296 0.77 0.22–2.63 0.7660 0.1429–2.6506 Svare 84/89 4/20 4.78 1.57–14.55 4.6869 1.4852–19.6399 Vaccarella 62/470 6/241 5.30 2.26–12.42 5.2905 2.2526–15.1850 Vardas; any HPV 417/1598 247/905 0.96 0.80–1.14 0.9561 0.7981–1.1469 Vardas; high risk 161/1854 115/1037 0.78 0.61–1.01 0.7831 0.6050–1.0161 Weaver STD clinic 0/3 10/17 0.24 0.01–5.08 0.4826 [0.0478]* –4.8700 Weaver University students 17/42 82/176 0.87 0.47–1.62 0.8691 0.4365–1.6708 Random effects summary effects: Any HPV 1.2411 1.02–1.51 High-risk HPV 1.1661 0.94–1.45 8 Selective HPV 1.0128 0.80–1.2
Brackets indicate that an infinite upper confidence interval was replaced with value equidistant from the odds ratio estimate as the lower confidence interval.
Data used in calculating Any HPV summary effect.
Data used in calculating high risk HPV summary effect. Any HPV: Heterogeneity chi-square (
) 39.98 (
). High-risk HPV: Heterogeneity chi-square (
) 45.27 (
). Selective HPV: Heterogeneity chi-square (
) 28.82 (
).